PNC Financial Services Group’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.63M Sell
43,822
-22,656
-34% -$1.88M ﹤0.01% 766
2025
Q1
$5.39M Sell
66,478
-14,960
-18% -$1.21M ﹤0.01% 641
2024
Q4
$7.33M Buy
81,438
+4,823
+6% +$434K ﹤0.01% 568
2024
Q3
$7.57M Sell
76,615
-4,359
-5% -$431K ﹤0.01% 566
2024
Q2
$7.51M Sell
80,974
-25,519
-24% -$2.37M 0.01% 555
2024
Q1
$10.1M Buy
106,493
+25,488
+31% +$2.42M 0.01% 514
2023
Q4
$7.23M Buy
81,005
+2,834
+4% +$253K 0.01% 561
2023
Q3
$5.71M Sell
78,171
-1,408
-2% -$103K ﹤0.01% 591
2023
Q2
$6.62M Sell
79,579
-3,124
-4% -$260K 0.01% 575
2023
Q1
$6.3M Buy
82,703
+5,421
+7% +$413K 0.01% 584
2022
Q4
$6.41M Buy
77,282
+6,550
+9% +$544K 0.01% 577
2022
Q3
$5.61M Sell
70,732
-5,525
-7% -$438K 0.01% 596
2022
Q2
$5.66M Sell
76,257
-8,419
-10% -$625K 0.01% 602
2022
Q1
$7.61M Sell
84,676
-4,078
-5% -$367K 0.01% 579
2021
Q4
$9.94M Buy
88,754
+632
+0.7% +$70.8K 0.01% 533
2021
Q3
$11.1M Sell
88,122
-87
-0.1% -$10.9K 0.01% 492
2021
Q2
$11.9M Buy
88,209
+6,296
+8% +$853K 0.01% 484
2021
Q1
$11.1M Sell
81,913
-13,729
-14% -$1.86M 0.01% 481
2020
Q4
$13.5M Buy
95,642
+20,182
+27% +$2.84M 0.01% 435
2020
Q3
$8.41M Buy
75,460
+8,966
+13% +$999K 0.01% 492
2020
Q2
$7.44M Buy
66,494
+34,581
+108% +$3.87M 0.01% 498
2020
Q1
$2.47M Buy
31,913
+5,467
+21% +$423K ﹤0.01% 692
2019
Q4
$2.52M Buy
26,446
+774
+3% +$73.6K ﹤0.01% 749
2019
Q3
$1.96M Buy
25,672
+1,368
+6% +$104K ﹤0.01% 979
2019
Q2
$2.13M Buy
24,304
+1,021
+4% +$89.5K ﹤0.01% 990
2019
Q1
$2.11M Buy
23,283
+2,099
+10% +$190K ﹤0.01% 1019
2018
Q4
$1.52M Sell
21,184
-7,233
-25% -$519K ﹤0.01% 1097
2018
Q3
$2.72M Buy
28,417
+7,186
+34% +$689K ﹤0.01% 964
2018
Q2
$2.02M Buy
21,231
+5,629
+36% +$536K ﹤0.01% 1039
2018
Q1
$1.37M Buy
15,602
+8,055
+107% +$707K ﹤0.01% 1184
2017
Q4
$640K Sell
7,547
-239
-3% -$20.3K ﹤0.01% 1525
2017
Q3
$674K Buy
7,786
+321
+4% +$27.8K ﹤0.01% 1469
2017
Q2
$576K Buy
7,465
+578
+8% +$44.6K ﹤0.01% 1540
2017
Q1
$477K Buy
6,887
+306
+5% +$21.2K ﹤0.01% 1643
2016
Q4
$390K Sell
6,581
-30,187
-82% -$1.79M ﹤0.01% 1720
2016
Q3
$2.44M Buy
36,768
+2,368
+7% +$157K ﹤0.01% 899
2016
Q2
$1.86M Sell
34,400
-156
-0.5% -$8.43K ﹤0.01% 970
2016
Q1
$1.79M Sell
34,556
-14,774
-30% -$764K ﹤0.01% 994
2015
Q4
$3.46M Buy
49,330
+5,795
+13% +$407K ﹤0.01% 709
2015
Q3
$2.71M Buy
43,535
+38,330
+736% +$2.39M ﹤0.01% 809
2015
Q2
$437K Buy
5,205
+1,989
+62% +$167K ﹤0.01% 1708
2015
Q1
$242K Buy
3,216
+2,001
+165% +$151K ﹤0.01% 2095
2014
Q4
$76K Buy
1,215
+75
+7% +$4.69K ﹤0.01% 2615
2014
Q3
$59K Sell
1,140
-153
-12% -$7.92K ﹤0.01% 2612
2014
Q2
$66K Sell
1,293
-300
-19% -$15.3K ﹤0.01% 2469
2014
Q1
$76K Sell
1,593
-858
-35% -$40.9K ﹤0.01% 2332
2013
Q4
$105K Buy
2,451
+987
+67% +$42.3K ﹤0.01% 2170
2013
Q3
$63K Buy
1,464
+246
+20% +$10.6K ﹤0.01% 2388
2013
Q2
$42K Buy
+1,218
New +$42K ﹤0.01% 2462